Latest News

New Muscat University to Open Doors in 2016

27th April 2014

All News | Financial News | Partners

Oxford University Innovation, an Oxford University company, partners with Muscat University to implement academic, research and knowledge transfer programmes.

Oxford Immunotec receives 2014 Queen’s Award for Enterprise

23rd April 2014

All News | Spinouts & Startups

Oxford University Innovation spin-out Oxford Immunotec has received a 2014 Queen’s Award for Enterprise.

Isis spin-out Organox closes series D round

16th April 2014

All News | Spinouts & Startups

OrganOx, a late-stage medical device company focused on increasing the quality and supply of organs for transplantation, has announced that it has closed a Series D Investment round.

Isis spin-out aims to 3D print synthetic tissues, organs

16th April 2014

All News | Spinouts & Startups | Technology News

A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery.

Oxford-Technikos venture capital deal yields tenth Oxford University Innovation spin-out

15th April 2014

All News | Financial News

The 2006 deal in which London-based venture capital fund Technikos provided £12m for the University of Oxford’s Institute of Biomedical Engineering (IBME) in return for half of the University’s equity in new companies based on IBME intellectual property, has notched up its tenth spin-out company.

Oxford University Innovation spin-out to manufacture designer spherical nanomaterials

14th April 2014

All News | Spinouts & Startups | Technology News

Next generation carbon nanomaterials such as graphene, carbon nanotubes and fullerenes, with their unique physical properties, have been hailed as “miracle materials”.

Immunocore shows promise in treating melanoma

9th April 2014

All News | Spinouts & Startups

Oxford-based Immunocore has announced that its immune therapy has shown promising early signs of efficacy in a Phase I trial in advanced melanoma patients.

New Drugs to Treat Duchenne Muscular Dystrophy

9th April 2014

All News | Spinouts & Startups | Technology News

Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.

University of Oxford Isis Fund closes, oversubscribed

7th April 2014

All News | Financial News

The University of Oxford Isis Fund, set up by Parkwalk Advisors and Oxford University Innovation, the University’s research commercialisation arm, has been successful in raising over £1.25m and will close, oversubscribed.

Immunocore’s T-cell receptor science still going strong

1st April 2014

All News | Spinouts & Startups

Phillip Campbell of Oxford Innovation Society member Milton Park talks to Immunocore’s Eva-Lotta Allan.

News

Ready to get in touch?